This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...
AUSTIN, Texas — Venous manometry and neuroimaging may provide additional value when diagnosing patients who do not meet criteria for idiopathic intracranial hypertension, according to a poster ...
WOMAN’S DOCTOR. NO ONE LIKES HAVING A HEADACHE THAT JUST DOESN’T GO AWAY. IT’S JUST THERE FOREVER. BUT ADD VISION ISSUES INTO THE EQUATION AND IT CAN BE REALLY TERRIFYING. THESE ARE SOME OF THE ...
Among women with idiopathic intracranial hypertension (IIH) and a body mass index (BMI) of 35 or higher, bariatric surgery was a more effective means of reducing intracranial pressure and sustaining ...
"IIH is a rapidly increasing health care concern for the US population," the investigators wrote. They noted that IIH treatments are limited making it difficult to manage the often-debilitating ...
Three neuro-ophthalmologists at the John A. Moran Eye Center, University of Utah, participated in a recent NIH-funded study that revealed the use of an inexpensive glaucoma drug (acetazolamide), when ...
Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes, may be a potential treatment for idiopathic intracranial hypertension (IIH). In a small phase 2 trial, ...
If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this ...
Glaucoma Drug, Plus Only 5-10 Percent Weight Loss Helps Restore Vision Loss to Patients with Idiopathic Intracranial Hypertension (IIH) National Institutes of Health (NIH)-Funded Study Published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback